Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

iBio, Inc. Common Stock

IBIO Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of IBIO by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
IBIO Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
IBIO Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
IBIO Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in IBIO holdings by institutional investors

Quarterly net insider trading by IBIO's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $70,000 Apr 18, 2022 Issue: Health Issues
  • $30,000 Apr 09, 2022 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs Health Issues
  • $30,000 Jan 16, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Health Issues
  • $70,000 Jan 13, 2022 Issue: HEALTH ISSUES
  • $30,000 Oct 20, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs Budget/Appropriations
  • $70,000 Oct 19, 2021 Issue: HEALTH ISSUES
  • $20,000 Jul 26, 2021 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations
  • $10,000 Jul 20, 2021 Issue: Health Issues
  • $30,000 Jul 17, 2021 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Health Issues
  • $70,000 Jul 08, 2021 Issue: HEALTH ISSUES
  • $20,000 Apr 20, 2021 Issue: Health Issues
  • $20,000 Apr 19, 2021 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $30,000 Apr 19, 2021 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Health Issues
  • $70,000 Apr 12, 2021 Issue: HEALTH ISSUES
  • $20,000 Jan 20, 2021 Issue: None
  • $70,000 Jan 18, 2021 Issue: HEALTH ISSUES
  • $10,000 Jan 16, 2021 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $40,000 Oct 20, 2020 Issue: None
  • $70,000 Oct 16, 2020 Issue: HEALTH ISSUES
  • $40,000 Jul 20, 2020 Issue: None
  • $70,000 Jul 15, 2020 Issue: HEALTH ISSUES
  • $70,000 Apr 17, 2020 Issue: HEALTH ISSUES
  • $70,000 Jan 21, 2020 Issue: HEALTH ISSUES
  • $60,000 Apr 22, 2019 Issue: Health Issues
  • $60,000 Jan 22, 2019 Issue: Health Issues
  • $40,000 Jan 20, 2019 Issue: Health Issues
  • $60,000 Jul 20, 2018 Issue: Health Issues
  • $40,000 Jul 20, 2018 Issue: Health Issues
  • $60,000 Apr 20, 2018 Issue: Health Issues
  • $40,000 Apr 17, 2018 Issue: Health Issues
  • $60,000 Jan 18, 2018 Issue: Health Issues
  • $10,000 Jan 10, 2018 Issue: Health Issues
  • $10,000 Oct 23, 2017 Issue: Health Issues
  • $60,000 Oct 20, 2017 Issue: Health Issues
  • $60,000 Jul 20, 2017 Issue: Health Issues
  • $60,000 Apr 20, 2017 Issue: Health Issues
  • $60,000 Jan 19, 2017 Issue: Health Issues
  • $60,000 Jan 20, 2016 Issue: Health Issues
  • $60,000 Oct 20, 2015 Issue: Health Issues
  • $60,000 Jul 16, 2015 Issue: Health Issues
  • $15,000 Apr 23, 2015 Issue: Health Issues
  • $70,000 Apr 25, 2014 Issue: None
  • $80,000 Jan 27, 2014 Issue: Medical/Disease Research/Clinical Labs
  • $75,000 Oct 16, 2013 Issue: Medical/Disease Research/Clinical Labs
  • $70,000 Jul 25, 2013 Issue: Medical/Disease Research/Clinical Labs
  • $60,000 Jul 24, 2013 Issue: Medical/Disease Research/Clinical Labs
  • $8,000 Jul 19, 2010 Issue: Budget/Appropriations
  • $10,000 Apr 13, 2010 Issue: Budget/Appropriations
  • $15,000 Jan 12, 2010 Issue: Budget/Appropriations
  • $15,000 Oct 20, 2009 Issue: Budget/Appropriations
  • $40,000 Feb 13, 2003 Issue: Health Issues Budget/Appropriations
  • $40,000 Aug 20, 2002 Issue: Health Issues Transportation Budget/Appropriations

Former government officials who have lobbied for IBIO

3 former government officials from 3 congressional offices at 2 lobbying firms have lobbied for IBIO, most recently Sep 30, 2022.

  • Cathy McMorris Rodgers
    Megan Perez Burke House Legislative Director & Health Policy Director, Congresswoman Cathy McMorris Rodgers Formerly with Cathy McMorris Rodgers · THE PETRIZZO GROUP, INC. · Sep 30, 2022
  • Kevin Brady
    Camille Lepire House Deputy Chief of Staff, Congressman Kevin Brady Formerly with Kevin Brady · THE PETRIZZO GROUP, INC. · Apr 09, 2022
  • Tom Cole
    Christopher Caron House New ​LD, Sr. Policy Advisor, Dep COS; Rep. Tom Cole Formerly with Tom Cole · STEPTOE LLP · May 19, 2020

IBIO Estimated quarterly lobbying spending

IBIO Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
IBIO Income Statement
IBIO Balance Sheet
IBIO Cash Flow
U.S. Patents

New IBIO patent grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to IBIO from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
IBIO News

Recent insights relating to IBIO

CNBC Recommendations

Recent picks made for IBIO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IBIO

IBIO Analyst Ratings

IBIO Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
IBIO Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $IBIO stock a Buy, Sell, or Hold?

  • What is the price target for $IBIO stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

IBIO Top Shareholders
Shareholder
Shares Held
IBIO Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $IBIO stock?

  • Who owns the most shares of $IBIO stock?

  • What funds own $IBIO stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

IBIO Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view IBIO Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About IBIO

iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.

  • Address New York, NY
  • Market Cap 76.5 million
  • Employees 23
  • Industrial Classification Pharmaceutical Preparations

iBio, Inc. Common Stock (IBIO) Historical Stock Prices

iBio, Inc. Common Stock (IBIO) closed at $1.19 on September 25, 2026. Over the past year its adjusted close ranged from $0.7913 to $3.07. Daily prices go back to January 2, 2014, 3,202 trading days in all.

  • 1 month-16.78%
  • 3 months-28.74%
  • Year to date-38.34%
  • 1 year+49.37%
  • 3 years-80.01%
  • 5 years-99.80%
  • Max-99.93%
See every congressional and insider trade on the IBIO price chart

Quiver Premium charts IBIO's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 1.23 1.24 1.15 1.19 1.19 621,018
Sep 24, 2026 1.25 1.25 1.19 1.20 1.20 378,016
Sep 23, 2026 1.32 1.35 1.24 1.25 1.25 363,824
Sep 22, 2026 1.28 1.37 1.24 1.33 1.33 2,093,406
Sep 21, 2026 1.29 1.30 1.26 1.26 1.26 389,438
Sep 18, 2026 1.26 1.30 1.24 1.28 1.28 445,362
Sep 17, 2026 1.25 1.31 1.21 1.25 1.25 2,090,481
Sep 16, 2026 1.19 1.20 1.17 1.18 1.18 407,174
Sep 15, 2026 1.20 1.22 1.17 1.19 1.19 375,779
Sep 14, 2026 1.23 1.23 1.20 1.20 1.20 325,262
Sep 11, 2026 1.24 1.24 1.20 1.21 1.21 184,893
Sep 10, 2026 1.26 1.26 1.22 1.23 1.23 309,089
Sep 9, 2026 1.30 1.30 1.25 1.26 1.26 410,928
Sep 8, 2026 1.31 1.32 1.28 1.30 1.30 191,782
Sep 4, 2026 1.29 1.33 1.28 1.31 1.31 265,443
Sep 3, 2026 1.32 1.35 1.29 1.30 1.30 354,194
Sep 2, 2026 1.26 1.33 1.26 1.31 1.31 311,033
Sep 1, 2026 1.27 1.30 1.21 1.26 1.26 2,233,662
Aug 31, 2026 1.37 1.37 1.25 1.27 1.27 875,831
Aug 28, 2026 1.42 1.42 1.34 1.36 1.36 521,248
Aug 27, 2026 1.43 1.46 1.40 1.40 1.40 376,759
Aug 26, 2026 1.47 1.47 1.43 1.43 1.43 259,165
Aug 25, 2026 1.41 1.48 1.41 1.47 1.47 436,011
Aug 24, 2026 1.45 1.45 1.37 1.42 1.42 514,909
Aug 21, 2026 1.46 1.50 1.42 1.43 1.43 755,205
Aug 20, 2026 1.47 1.50 1.44 1.47 1.47 1,977,105
Aug 19, 2026 1.47 1.50 1.42 1.49 1.49 839,378
Aug 18, 2026 1.45 1.47 1.40 1.45 1.45 2,794,827
Aug 17, 2026 1.45 1.48 1.42 1.45 1.45 589,283
Aug 14, 2026 1.38 1.44 1.34 1.43 1.43 522,573
Aug 13, 2026 1.48 1.48 1.38 1.40 1.40 507,810
Aug 12, 2026 1.47 1.54 1.46 1.47 1.47 599,651
Aug 11, 2026 1.41 1.50 1.37 1.47 1.47 375,066
Aug 10, 2026 1.41 1.43 1.39 1.40 1.40 479,116
Aug 7, 2026 1.40 1.43 1.38 1.41 1.41 436,394
Aug 6, 2026 1.40 1.41 1.36 1.39 1.39 424,306
Aug 5, 2026 1.46 1.48 1.39 1.40 1.40 304,807
Aug 4, 2026 1.46 1.49 1.44 1.46 1.46 486,241
Aug 3, 2026 1.44 1.44 1.38 1.42 1.42 470,289
Jul 31, 2026 1.41 1.47 1.34 1.40 1.40 728,593
Jul 30, 2026 1.36 1.42 1.35 1.39 1.39 422,403
Jul 29, 2026 1.39 1.41 1.29 1.36 1.36 802,898
Jul 28, 2026 1.45 1.45 1.33 1.39 1.39 1,013,418
Jul 27, 2026 1.44 1.47 1.35 1.45 1.45 1,045,545
Jul 24, 2026 1.40 1.47 1.31 1.43 1.43 1,213,322
Jul 23, 2026 1.35 1.41 1.33 1.40 1.40 464,669
Jul 22, 2026 1.40 1.41 1.35 1.38 1.38 370,362
Jul 21, 2026 1.38 1.42 1.35 1.41 1.41 384,731
Jul 20, 2026 1.44 1.44 1.35 1.37 1.37 394,897
Jul 17, 2026 1.34 1.44 1.31 1.38 1.38 603,078
Jul 16, 2026 1.43 1.44 1.28 1.35 1.35 1,469,633
Jul 15, 2026 1.47 1.50 1.43 1.43 1.43 984,181
Jul 14, 2026 1.47 1.48 1.42 1.44 1.44 1,109,019
Jul 13, 2026 1.48 1.56 1.45 1.45 1.45 1,076,544
Jul 10, 2026 1.52 1.53 1.43 1.51 1.51 894,768
Jul 9, 2026 1.52 1.56 1.51 1.51 1.51 1,160,685
Jul 8, 2026 1.57 1.62 1.50 1.52 1.52 1,499,011
Jul 7, 2026 1.65 1.65 1.57 1.59 1.59 463,257
Jul 6, 2026 1.71 1.74 1.62 1.62 1.62 466,964
Jul 2, 2026 1.76 1.77 1.66 1.68 1.68 764,006
Jul 1, 2026 1.76 2.11 1.71 1.75 1.75 5,047,019
Jun 30, 2026 1.73 1.75 1.71 1.75 1.75 440,570
Jun 29, 2026 1.66 1.80 1.64 1.73 1.73 1,120,112
Jun 26, 2026 1.60 1.68 1.57 1.67 1.67 1,512,777
Jun 25, 2026 1.64 1.65 1.58 1.59 1.59 371,557
Jun 24, 2026 1.68 1.69 1.62 1.62 1.62 402,332
Jun 23, 2026 1.70 1.75 1.65 1.65 1.65 931,406
Jun 22, 2026 1.70 1.76 1.68 1.74 1.74 904,672
Jun 18, 2026 1.61 1.73 1.61 1.69 1.69 912,081
Jun 17, 2026 1.57 1.63 1.48 1.60 1.60 1,671,167
Jun 16, 2026 1.66 1.67 1.55 1.55 1.55 1,049,310
Jun 15, 2026 1.70 1.75 1.65 1.65 1.65 753,999
Jun 12, 2026 1.70 1.76 1.67 1.69 1.69 455,655
Jun 11, 2026 1.69 1.71 1.64 1.67 1.67 353,438
Jun 10, 2026 1.70 1.78 1.65 1.70 1.70 507,215
Jun 9, 2026 1.78 1.80 1.66 1.70 1.70 410,048
Jun 8, 2026 1.87 1.89 1.73 1.73 1.73 641,584
Jun 5, 2026 1.93 2.09 1.73 1.82 1.82 2,285,556
Jun 4, 2026 1.83 2.00 1.83 1.93 1.93 854,852
Jun 3, 2026 1.79 1.85 1.70 1.84 1.84 725,421
Jun 2, 2026 1.89 1.92 1.71 1.76 1.76 1,136,838
Jun 1, 2026 1.90 1.93 1.82 1.89 1.89 524,320
May 29, 2026 1.92 1.93 1.88 1.90 1.90 324,272
May 28, 2026 1.88 1.99 1.86 1.93 1.93 745,762
May 27, 2026 1.82 1.97 1.81 1.88 1.88 593,117
May 26, 2026 1.89 1.91 1.80 1.82 1.82 1,105,669
May 22, 2026 1.93 2.00 1.82 1.84 1.84 600,814
May 21, 2026 1.70 1.95 1.70 1.89 1.89 1,425,366
May 20, 2026 1.51 1.74 1.51 1.70 1.70 734,263
May 19, 2026 1.42 1.54 1.38 1.50 1.50 780,006
May 18, 2026 1.49 1.50 1.40 1.42 1.42 761,670
May 15, 2026 1.54 1.54 1.45 1.47 1.47 425,632
May 14, 2026 1.56 1.57 1.51 1.56 1.56 706,615
May 13, 2026 1.62 1.62 1.54 1.55 1.55 681,933
May 12, 2026 1.66 1.67 1.59 1.61 1.61 396,891
May 11, 2026 1.73 1.74 1.63 1.66 1.66 663,700
May 8, 2026 1.64 1.75 1.59 1.71 1.71 1,835,398
May 7, 2026 1.76 1.79 1.62 1.64 1.64 372,003
May 6, 2026 1.61 1.77 1.59 1.77 1.77 1,923,478
May 5, 2026 1.61 1.65 1.55 1.61 1.61 796,680
May 4, 2026 1.62 1.65 1.52 1.58 1.58 2,153,205
May 1, 2026 1.65 1.68 1.56 1.59 1.59 693,571
Apr 30, 2026 1.60 1.70 1.54 1.69 1.69 2,987,023
Apr 29, 2026 1.61 1.62 1.52 1.62 1.62 927,649
Apr 28, 2026 1.68 1.74 1.62 1.63 1.63 653,126
Apr 27, 2026 1.68 1.73 1.62 1.71 1.71 955,631
Apr 24, 2026 1.80 1.85 1.67 1.68 1.68 1,161,356
Apr 23, 2026 1.93 1.93 1.74 1.81 1.81 1,266,851
Apr 22, 2026 1.94 1.96 1.85 1.92 1.92 759,074
Apr 21, 2026 2.00 2.02 1.91 1.92 1.92 559,071
Apr 20, 2026 2.04 2.09 1.91 1.97 1.97 888,930
Apr 17, 2026 2.14 2.19 2.04 2.06 2.06 776,340
Apr 16, 2026 2.12 2.15 2.06 2.11 2.11 689,102
Apr 15, 2026 2.18 2.24 2.08 2.10 2.10 685,420
Apr 14, 2026 2.23 2.25 2.18 2.19 2.19 458,359
Apr 13, 2026 2.12 2.25 2.12 2.20 2.20 539,624
Apr 10, 2026 2.17 2.20 2.11 2.16 2.16 513,920
Apr 9, 2026 2.23 2.26 2.15 2.20 2.20 561,518
Apr 8, 2026 2.27 2.29 2.16 2.24 2.24 781,969
Apr 7, 2026 2.02 2.14 1.98 2.11 2.11 640,157
Apr 6, 2026 1.99 2.09 1.99 2.03 2.03 501,680
Apr 2, 2026 1.87 2.01 1.87 1.98 1.98 321,088
Apr 1, 2026 1.94 2.02 1.93 1.95 1.95 501,135
Mar 31, 2026 1.70 1.96 1.70 1.90 1.90 802,950
Mar 30, 2026 1.80 1.81 1.69 1.71 1.71 430,102
Mar 27, 2026 1.71 1.88 1.70 1.76 1.76 1,265,373
Mar 26, 2026 1.65 1.80 1.43 1.74 1.74 6,281,060
Mar 25, 2026 2.15 2.24 2.12 2.18 2.18 678,118
Mar 24, 2026 2.20 2.24 2.04 2.08 2.08 901,915
Mar 23, 2026 2.28 2.30 2.15 2.21 2.21 683,672
Mar 20, 2026 2.07 2.15 2.00 2.09 2.09 1,206,427
Mar 19, 2026 2.20 2.21 1.98 2.10 2.10 1,200,387
Mar 18, 2026 2.49 2.50 2.17 2.19 2.19 615,665
Mar 17, 2026 2.41 2.49 2.35 2.46 2.46 301,626
Mar 16, 2026 2.49 2.59 2.38 2.39 2.39 561,756
Mar 13, 2026 2.53 2.75 2.38 2.45 2.45 1,176,466
Mar 12, 2026 2.40 2.57 2.33 2.49 2.49 760,732
Mar 11, 2026 2.38 2.52 2.31 2.43 2.43 896,732
Mar 10, 2026 2.52 2.63 2.35 2.38 2.38 620,229
Mar 9, 2026 2.54 2.54 2.33 2.50 2.50 1,624,928
Mar 6, 2026 2.59 2.65 2.53 2.61 2.61 335,233
Mar 5, 2026 2.79 2.83 2.50 2.64 2.64 1,590,512
Mar 4, 2026 2.69 2.85 2.60 2.83 2.83 709,500
Mar 3, 2026 2.65 2.74 2.47 2.69 2.69 1,025,510
Mar 2, 2026 2.56 2.79 2.40 2.69 2.69 1,015,201
Feb 27, 2026 3.01 3.12 2.76 2.82 2.82 1,396,790
Feb 26, 2026 2.81 3.13 2.78 3.07 3.07 1,579,838
Feb 25, 2026 2.53 2.88 2.48 2.87 2.87 3,235,779
Feb 24, 2026 2.43 2.72 2.41 2.47 2.47 1,495,189
Feb 23, 2026 2.35 2.50 2.32 2.45 2.45 699,686
Feb 20, 2026 2.40 2.46 2.37 2.38 2.38 447,016
Feb 19, 2026 2.30 2.47 2.29 2.45 2.45 1,224,874
Feb 18, 2026 2.30 2.36 2.25 2.33 2.33 468,409
Feb 17, 2026 2.19 2.33 2.17 2.29 2.29 588,065
Feb 13, 2026 2.11 2.33 2.11 2.22 2.22 724,292
Feb 12, 2026 2.20 2.20 2.02 2.11 2.11 1,256,427
Feb 11, 2026 2.32 2.32 2.09 2.21 2.21 1,027,772
Feb 10, 2026 2.42 2.45 2.23 2.27 2.27 1,620,162
Feb 9, 2026 2.41 2.50 2.27 2.41 2.41 917,067
Feb 6, 2026 2.20 2.50 2.20 2.42 2.42 2,118,875
Feb 5, 2026 2.11 2.22 2.08 2.15 2.15 976,174
Feb 4, 2026 2.24 2.26 2.02 2.20 2.20 1,109,094
Feb 3, 2026 2.32 2.36 2.23 2.24 2.24 915,030
Feb 2, 2026 2.06 2.35 2.04 2.30 2.30 1,488,143
Jan 30, 2026 2.10 2.20 2.06 2.10 2.10 1,151,783
Jan 29, 2026 2.21 2.21 2.10 2.15 2.15 580,106
Jan 28, 2026 2.26 2.37 2.20 2.23 2.23 521,234
Jan 27, 2026 2.13 2.29 2.06 2.28 2.28 976,635
Jan 26, 2026 2.25 2.26 2.11 2.15 2.15 1,259,859
Jan 23, 2026 2.38 2.47 2.25 2.25 2.25 726,910
Jan 22, 2026 2.30 2.41 2.19 2.39 2.39 1,774,466
Jan 21, 2026 2.25 2.37 2.15 2.24 2.24 1,241,498
Jan 20, 2026 2.15 2.35 2.10 2.24 2.24 1,363,577
Jan 16, 2026 2.20 2.32 2.17 2.20 2.20 891,062
Jan 15, 2026 2.49 2.51 2.18 2.21 2.21 2,438,816
Jan 14, 2026 2.48 2.64 2.33 2.49 2.49 1,997,169
Jan 13, 2026 2.70 2.76 2.44 2.54 2.54 1,978,302
Jan 12, 2026 2.64 2.89 2.38 2.70 2.70 3,369,629
Jan 9, 2026 2.62 2.75 2.50 2.70 2.70 12,747,136
Jan 8, 2026 2.18 2.35 2.18 2.35 2.35 1,928,910
Jan 7, 2026 2.12 2.29 1.98 2.17 2.17 4,543,196
Jan 6, 2026 2.25 2.68 2.04 2.06 2.06 18,371,709
Jan 5, 2026 2.04 2.06 1.82 1.88 1.88 1,085,451
Jan 2, 2026 1.95 2.12 1.87 2.02 2.02 1,422,839
Dec 31, 2025 1.70 1.95 1.70 1.93 1.93 1,013,563
Dec 30, 2025 1.83 1.83 1.71 1.71 1.71 700,578
Dec 29, 2025 1.90 1.96 1.82 1.85 1.85 1,740,843
Dec 26, 2025 1.88 1.91 1.78 1.89 1.89 891,992
Dec 24, 2025 1.90 1.99 1.83 1.87 1.87 869,102
Dec 23, 2025 2.04 2.05 1.88 1.88 1.88 1,301,465
Dec 22, 2025 1.98 2.14 1.91 2.01 2.01 2,009,549
Dec 19, 2025 1.89 1.99 1.86 1.98 1.98 1,674,062
Dec 18, 2025 2.00 2.13 1.87 1.88 1.88 1,283,042
Dec 17, 2025 2.05 2.13 1.85 1.89 1.89 1,917,299
Dec 16, 2025 1.85 2.15 1.82 2.06 2.06 3,382,791
Dec 15, 2025 1.99 2.12 1.82 1.83 1.83 2,870,298
Dec 12, 2025 2.35 2.38 1.83 1.94 1.94 8,096,400
Dec 11, 2025 2.73 2.90 2.28 2.42 2.42 9,860,833
Dec 10, 2025 2.20 3.82 2.04 2.81 2.81 67,058,973
Dec 9, 2025 1.98 2.44 1.93 2.22 2.22 48,040,412
Dec 8, 2025 1.93 2.28 1.54 1.67 1.67 113,856,479
Dec 5, 2025 1.25 1.27 1.17 1.20 1.20 628,534
Dec 4, 2025 1.05 1.30 1.03 1.28 1.28 2,362,264
Dec 3, 2025 1.04 1.07 0.9800 1.04 1.04 1,346,414
Dec 2, 2025 1.09 1.12 1.06 1.07 1.07 780,603
Dec 1, 2025 1.19 1.19 1.10 1.10 1.10 854,365
Nov 28, 2025 1.18 1.23 1.17 1.23 1.23 447,277
Nov 26, 2025 1.20 1.21 1.13 1.20 1.20 945,612
Nov 25, 2025 1.12 1.20 1.08 1.17 1.17 707,552
Nov 24, 2025 1.06 1.14 1.06 1.11 1.11 799,438
Nov 21, 2025 1.00 1.07 0.9610 1.05 1.05 683,911
Nov 20, 2025 1.09 1.13 0.9901 0.9951 0.9951 1,036,373
Nov 19, 2025 1.23 1.25 1.06 1.09 1.09 1,222,666
Nov 18, 2025 1.12 1.27 1.11 1.21 1.21 1,268,402
Nov 17, 2025 1.16 1.28 1.08 1.10 1.10 2,010,106
Nov 14, 2025 1.10 1.20 1.10 1.16 1.16 821,841
Nov 13, 2025 1.24 1.24 1.11 1.15 1.15 1,929,545
Nov 12, 2025 1.24 1.30 1.21 1.25 1.25 843,918
Nov 11, 2025 1.26 1.28 1.21 1.24 1.24 853,166
Nov 10, 2025 1.38 1.38 1.27 1.29 1.29 767,723
Nov 7, 2025 1.31 1.34 1.18 1.32 1.32 1,666,161
Nov 6, 2025 1.42 1.44 1.30 1.39 1.39 1,697,204
Nov 5, 2025 1.50 1.53 1.42 1.44 1.44 1,638,197
Nov 4, 2025 1.76 1.76 1.46 1.53 1.53 2,954,614
Nov 3, 2025 1.65 1.81 1.61 1.76 1.76 4,052,235
Oct 31, 2025 1.52 1.65 1.46 1.60 1.60 2,048,965
Oct 30, 2025 1.69 1.78 1.38 1.55 1.55 15,156,830
Oct 29, 2025 1.39 1.57 1.29 1.54 1.54 4,361,329
Oct 28, 2025 1.25 1.47 1.24 1.39 1.39 3,318,991
Oct 27, 2025 1.24 1.32 1.14 1.28 1.28 2,592,388
Oct 24, 2025 1.26 1.27 1.14 1.21 1.21 4,253,831
Oct 23, 2025 1.70 1.72 1.18 1.27 1.27 29,642,711
Oct 22, 2025 1.03 1.58 1.01 1.39 1.39 26,729,257
Oct 21, 2025 1.08 1.47 1.05 1.11 1.11 62,984,829
Oct 20, 2025 0.8676 0.9053 0.8642 0.8930 0.8930 5,036,174
Oct 17, 2025 0.8580 0.9100 0.8412 0.8500 0.8500 738,491
Oct 16, 2025 0.8460 0.8701 0.8231 0.8455 0.8455 346,641
Oct 15, 2025 0.8033 0.8495 0.8033 0.8495 0.8495 492,869
Oct 14, 2025 0.7911 0.8197 0.7900 0.8002 0.8002 210,561
Oct 13, 2025 0.7913 0.8237 0.7910 0.8086 0.8086 267,405
Oct 10, 2025 0.8500 0.8539 0.7811 0.7913 0.7913 451,240
Oct 9, 2025 0.8798 0.8798 0.8332 0.8540 0.8540 253,226
Oct 8, 2025 0.8770 0.8900 0.8451 0.8663 0.8663 297,391
Oct 7, 2025 0.8500 0.8785 0.8401 0.8693 0.8693 372,569
Oct 6, 2025 0.8595 0.8595 0.8266 0.8498 0.8498 380,551
Oct 3, 2025 0.8210 0.8644 0.8210 0.8595 0.8595 420,050
Oct 2, 2025 0.8099 0.8480 0.8099 0.8339 0.8339 211,893
Oct 1, 2025 0.8277 0.8277 0.8050 0.8238 0.8238 171,342
Sep 30, 2025 0.8080 0.8364 0.8011 0.8278 0.8278 180,294
Sep 29, 2025 0.8000 0.8500 0.8000 0.8365 0.8365 321,701
Sep 26, 2025 0.7800 0.8198 0.7800 0.8110 0.8110 178,470
Sep 25, 2025 0.8181 0.8287 0.7847 0.7967 0.7967 268,402

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
iBio, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at IBIO, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation